109 related articles for article (PubMed ID: 10575141)
1. Iron chelators as anti-infectives; malaria as a paradigm.
Cabantchik ZI; Moody-Haupt S; Gordeuk VR
FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):289-98. PubMed ID: 10575141
[TBL] [Abstract][Full Text] [Related]
2. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
[TBL] [Abstract][Full Text] [Related]
3. Clinical studies of iron chelators in malaria.
Mabeza GF; Biemba G; Gordeuk VR
Acta Haematol; 1996; 95(1):78-86. PubMed ID: 8604591
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Macromolecular Iron Chelators.
Bulbake U; Singh A; Domb AJ; Khan W
Curr Med Chem; 2019; 26(2):323-334. PubMed ID: 30182850
[TBL] [Abstract][Full Text] [Related]
5. Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators.
Hershko C
Baillieres Clin Haematol; 1994 Dec; 7(4):965-1000. PubMed ID: 7881162
[TBL] [Abstract][Full Text] [Related]
6. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
[TBL] [Abstract][Full Text] [Related]
7. Control of malaria by drug-mediated iron deprivation.
Hershko C; Cabantchik ZI
Isr J Med Sci; 1994 Nov; 30(11):840-5. PubMed ID: 7982777
[No Abstract] [Full Text] [Related]
8. Iron chelators: mode of action as antimalarials.
Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
[TBL] [Abstract][Full Text] [Related]
9. [Research progress on iron chelator for malaria therapy].
Huang F; Tang LH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Aug; 23(4):250-3. PubMed ID: 16296623
[No Abstract] [Full Text] [Related]
10. Falciparum malaria: the urgent need for safe and effective drugs.
Rieckmann KH
Annu Rev Med; 1983; 34():321-35. PubMed ID: 6344762
[TBL] [Abstract][Full Text] [Related]
11. Malaria and iron: history and review.
Weinberg ED; Moon J
Drug Metab Rev; 2009; 41(4):644-62. PubMed ID: 19764831
[TBL] [Abstract][Full Text] [Related]
12. The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release.
Golenser J; Domb A; Teomim D; Tsafack A; Nisim O; Ponka P; Eling W; Cabantchik ZI
J Pharmacol Exp Ther; 1997 Jun; 281(3):1127-35. PubMed ID: 9190845
[TBL] [Abstract][Full Text] [Related]
13. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
[TBL] [Abstract][Full Text] [Related]
14. UK malaria treatment guidelines.
Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
[TBL] [Abstract][Full Text] [Related]
15. Thalassemia.
Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
[TBL] [Abstract][Full Text] [Related]
16. In vivo antimalarial action of a lipophilic iron (III) chelator: suppression of Plasmodium vinckei infection by reversed siderophore.
Lytton SD; Loyevsky M; Mester B; Libman J; Landau I; Shanzer A; Cabantchik ZI
Am J Hematol; 1993 Jul; 43(3):217-20. PubMed ID: 8352239
[TBL] [Abstract][Full Text] [Related]
17. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
Na-Bangchang K; Karbwang J
Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
[TBL] [Abstract][Full Text] [Related]
18. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
[TBL] [Abstract][Full Text] [Related]
19. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant malaria: molecular mechanisms and implications for public health.
Petersen I; Eastman R; Lanzer M
FEBS Lett; 2011 Jun; 585(11):1551-62. PubMed ID: 21530510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
